Nadir Ali, MD
Interventional cardiologist (30+ years); former Chairman of Cardiology, Clear Lake Regional Medical Center
A practising interventional cardiologist who, from direct clinical experience, concluded that LDL is not causally related to heart disease and that insulin resistance is the primary driver. His argument from hands-on experience carries a different texture than bench or trial evidence, though it is observational and selective.
Position (a lossy summary - the nuance is below)
LDL: benign to causal
-0.85 (strongly toward "LDL benign")
States he sees no correlation between cholesterol levels and disease across roughly 10,000 patients, argues LDL serves important physiological functions (energy transport, immune defence), and views the LDL rise on low-carb diets as benign metabolic adaptation.
Statins: anti to pro
-0.60 (toward "Anti-statin")
Questions whether landmark statin trials are as compelling as claimed, arguing benefits have been exaggerated via relative-risk framing; focuses on metabolic health over lipid lowering.
One of few actively practising interventional cardiologists who openly disputes LDL causality. His mechanistic arguments for LDL''s biological functions are interesting; his core evidence (clinical observation) is uncontrolled and vulnerable to confounding and selection.
Key arguments
- No correlation between cholesterol level and disease in ~10,000 patients he has treated.
- LDL has critical biological roles (nutrient/vitamin transport, immune defence).
- Insulin resistance, not LDL, drives atherosclerosis; LDL rise on low-carb is benign adaptation.
Positions on specific claims
- Does LDL cholesterol actually cause heart disease?
Rejects LDL causality based on clinical observation and LDL's physiological functions.
- Does metabolic health change how dangerous a given LDL level is?
Argues insulin resistance and LDL particle quality are what matter.
Conflicts of interest
Produces content with low-carb/carnivore-aligned platforms and operates a lifestyle-focused practice; a public profile tied to the LDL-skeptic position.
Fair criticisms
- Argument from personal clinical observation is uncontrolled and prone to confounding/selection bias.
- Dismisses the Mendelian-randomization and trial evidence that underpins LDL causality.